Effects of quinpirole on operant conditioning: Perseveration of behavioral components

Behavioural Brain Research

Volumn 155, Issue 1, 2004, Pages 117-124

  Kurylo, Daniel D ^a  

^a CITY UNIVERSITY OF NEW YORK   (United States)

Author keywords

Extinction; Operant; Perseveration; Quinpirole; Reinforcement; Stereotypy

Indexed keywords

QUINPIROLE;

AROUSAL; ARTICLE; CONTROLLED STUDY; DRINKING; DRUG EFFECT; INSTRUMENTAL CONDITIONING; NONHUMAN; PRIORITY JOURNAL; RAT; REINFORCEMENT; TASK PERFORMANCE;

ANALYSIS OF VARIANCE; ANIMALS; BEHAVIOR, ANIMAL; CONDITIONING, OPERANT; DOPAMINE AGONISTS; DOSE-RESPONSE RELATIONSHIP, DRUG; DRINKING BEHAVIOR; EXTINCTION, PSYCHOLOGICAL; PSYCHOMOTOR PERFORMANCE; QUINPIROLE; RATS; RATS, LONG-EVANS; TIME FACTORS;

EID: 4344700352     PISSN: 01664328     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bbr.2004.04.015     Document Type: Article

References (52)

1. Agmo A., Federman I., Navarro V., Padua M., Velazquez G. Reward and reinforcement produced by drinking water: role of opioids and dopamine receptor subtypes. Pharmacol. Biochem. Behav. 46:1993;183-194
2. Beninger R.J. A comparison of the effects of pimozide and nonreinforcement on discriminated operant responding in rats. Pharmacol. Biochem. Behav. 16:1982;667-669
3. Beninger R.J. Dissociating the effects of altered dopaminergic function on performance and learning. Brain Res. Bull. 23:1989;365-371
4. Beninger R.J., Cheng M., Hahn B.L., Hoffman D.C., Mazurski E.J., Morency M.A., et al. Effects of extinction, pimozide, SCH 23390, and metoclopramide on food-rewarded operant responding of rats. Psychopharmacology. 92:1987;343-349
5. Beninger R.J., Mazurski E.J., Hoffman D.C. Receptor subtype-specific dopaminergic agents and unconditioned behavior. Pol. J. Pharmacol. Pharm. 43:1991;507-528
6. Ben-Pazi A., Szechtman H., Eilam D. The morphogenesis of motor rituals in rats treated chronically with the dopamine agonist quinpirole. Behav. Neurosci. 115:2001;1301-1317
7. Cory-Slechta D.A., Pazmino R., Bare C. The critical role of nucleus accumbens dopamine systems in the mediation of fixed interval schedule-controlled operant behavior. Brain Res. 764:1997;253-256
8. Depoortere R., Perrault G.H., Sanger D.J. Behavioural effects in the rat of the putative dopamine D3 receptor agonist 7-OH-DPAT: comparison with quinpirole and apomorphine. Psychopharmacology. 14:1996;231-240
9. Eilam D., Clements K.V.A., Szechtman H. Differential effects of D1 and D2 dopamine agonists on stereotyped locomotion in rats. Behav. Brain Res. 45:1991;117-124
10. Eilam D., Golani I., Szechtman H. D2 agonsit quinpirole induces perseveration of routes and hyperactivity but no perseveration of movements. Brain Res. 490:1989;255-267
11. Eilam D., Talangbayan H., Canaran G., Szechtman H. Dopaminergic control of locomotion, mouthing, snout contact, and grooming: opposing roles of D1 and D2 receptors. Psychopharmacology. 106:1992;447-454
12. Einat H., Szechtman H. Perseveration without hyperlocomotion in a spontaneous alternation task in rats sensitized to the dopamine agonist quinpirole. Physiol. Behav. 57:1995;55-59
13. Furmidge L., Tong Z.Y., Petry N., Clark D. Effects of low, autoreceptor selective doses of dopamine agonists on the discriminative cue and locomotor hyperactivity produced by D-amphetamine. J. Neural Transm. Gen. Sect. 86:1991;61-70
14. Gerber G.J., Sing J., Wise R.A. Pimozide attenuates lever pressing for water reinforcement in rats. Pharmacol. Biochem. Behav. 14:1981;201-205
15. Gold L.H., Geyer M.A., Koob G.F. Neurochemical mechanisms involved in behavioral effects of amphetamines and related designer drugs. NIDA Res. Monogr. 94:1989;101-126
16. Gray T., Wise R.A. Effects of pimozide on lever pressing behavior maintained on an intermittent reinforcement schedule. Pharmacol. Biochem. Behav. 12:1980;931-935
17. Horvitz J.C., Williams G., Joy R. Time-dependent actions of D2 family agonist quinpirole on spontaneous behavior in the rat: dissociation between sniffing and locomotion. Psychopharmacology. 154:2001;350-355
18. Jackson M.E., Moghaddam B. Amygdala regulation of nucleus accumbens dopamine output is governed by the prefrontal cortex. J. Neurosci. 21:2001;676-681
19. Kiyatkin E.A., Gratton A. Electrochemical monitoring of extracellular dopamine in nucleus accumbens of rats lever-pressing for food. Brain Res. 652:1994;225-234
20. Kostrzewa R.M. Dopamine receptor supersensitivity. Neurosci. Biobehav. Rev. 19:1995;1-17
21. Kurylo D.D., Tanguay S. Effects of quinpirole on behavioral extinction. Physiol. Behav. 80:2003;1-7
22. Ljungberg T. Attenuation of water intake and operant responding by dopamine D2 antagonists: raclopride provides important cues for understanding the functional mechanism of action. Pharmacol. Toxicol. 65:1989;9-12
23. Ljungberg T. Effects of the dopamine D-1 antagonist SCH 23390 on water intake. Biochem. Behav. 33:1989;709-712
24. McCullough L.D., Cousins M.S., Salamone J.D. The role of nucleus accumbens dopamine in responding on a continuous reinforcement operant schedule: a neurochemical and behavioral study. Pharmacol. Biochem. Behav. 46:1993;581-586
25. Morley M.J., Bradshaw C.M., Szabadi E. Attenuation by pimozide of the suppressant effect of D-amphetamine on operant behavior. Psychopharmacology. 91:1987;239-243
26. Moy S.S. Impaired acquisition and operant responding after neonatal dopamine depletion in rats. Pharmacol. Biochem. Behav. 52:1995;433-441
27. Nakajima S. Subtypes of dopamine receptors involved in the mechanism of reinforcement. Neurosci. Biobehav. Rev. 13:1989;123-128
28. Nakajima S., Baker J.D. Effects of D2 dopamine receptor blockade with raclopride on intracranial self-stimulation and food-reinforced operant behavior. Psychopharmacology. 98:1989;330-333
29. Peng Ry., Mansbach R.S., Braff D.L., Geyer M.A. A D2 dopamine receptor agonist disrupts sensorimotor gating in rats. Implications for dopaminergic abnormalities in schizophrenia. Neuropsychopharmacology. 3:1990;211-218
30. Ridley R.M., Clark B.A., Durnford L.J., Baker H.F. Stimulus-bound perseveration after frontal ablations in marmosets. Neuroscience. 52:1993;595-604
31. Salamone J.D. Complex motor and sensorimotor functions of accumbens and striatal dopamine: involvement in instrumental behavioral processes. Psychopharmacology. 107:1992;160-174
32. Salamone J.D., Cousins M.S., McCullough L.D., Carriero D.L., Berkowitz R.J. Nucleus accumbens dopamine release increases during instrumental level pressing for food but not free food consumption. Pharmacol. Biochem. Behav. 49:1994;25-31
33. Salamone J.D., Kurth P.A., McCullough L.D., Sokolowski J.D. The effects of nucleus accumbens dopamine depletions on continuously reinforced operant responding: contrasts with the effects of extinction. Pharmacol. Biochem. Behav. 50:1995;437-443
34. Salamone J.D., Kurth P.A., McCullough L.D., Sokolowski J.D., Cousins M.S. The role of brain dopamine in response initiation: effects of haloperidol and regionally specific dopamine depletions on the local rate of instrumental responding. Brain Res. 628:1993;218-226
35. Salmi P., Sproat B.S., Ludwig J., Hale R., Avery N., Kela J., et al. Dopamine D2 receptor ribozyme inhibits quinpirole-induced stereotypy in rats. Eur. J. Pharmacol. 388:2000;R1-R2
36. Sandson J., Albert M.L. Perseveration in behavioral neurology. Neurology. 37:1987;1736-1741
37. Sanger D.J. Response decrement patterns after neuroleptic and non-neuroleptic drugs. Psychopharmacology. 89:1986;98-104
38. Sanger D.J. The actions of SCH 23390, a D1 receptor antagonist, on operant and avoidance behavior in rats. Pharmacol. Biochem. Behav. 26:1987;509-513
39. Schultz W. Predictive reward signal of dopamine neurons. J. Neurophysiol. 80:1998;1-27
40. Skitek E.B., Fowler S.C., Tessel R.E. Effects of unilateral striatal dopamine depletion on tongue force and rhythm during licking in rats. Behav. Neurosci. 113:1999;567-573
41. Snodgrass S.H., Allen J.D. Effects of dopamine agents on schedule- and deprivation-induced drinking in rats. Pharmacol. Biochem. Behav. 27:1987;463-475
42. Sokolowski J.D., Salamone J.D. The role of accumbens dopamine in lever pressing and response allocation: effects of 6-OHDA injected into core and dorsomedial shell. Pharmacol. Biochem. Behav. 59:1998;557-566
43. Sullivan R., Dogura C., Szechtman H. Constriction of environmental space and the behavioral response to the dopamine agonist quinpirole. Pharmacol. Biochem. Behav. 43:1992;1217-1219
44. Szechtman H., Talangbayan H., Canaran G., Dai H., Eilam D. Dynamics of behavioral sensitization induced by the dopamine agonist quinpirole and a proposed central energy control mechanism. Psychopharmacology. 115:1994;95-104
45. Szechtman H., Sulis W., Eilam D. Quinpirole induces compulsive checking behavior in rats: a potential animal model of obsessive-compulsive disorder OCD. Behav. Neurosci. 112:1998;1475-1485
46. Szechtman H., Culver K., Eilam D. Role of dopamine systems in obsessive-compulsive disorder OCD: implications from a psychostimulant-induced animal model. Pol. J. Pharmacol. 51:1999;55-61
47. Tombaugh T.N., Tombaugh J., Anisman H. Effects of dopamine receptor blockade on alimentary behaviors: home cage food consumption, magazine training, operant acquisition, and performance. Psychopharmacology. 66:1979;219-225
48. Tombaugh T.N., Anisman H., Tombaugh J. Extinction and dopamine receptor blockade after intermittent reinforcement training: failure to observe functional equivalence. Psychopharmacology. 70:1980;19-28
49. White N.M., Packard M.G., Seamans J. Memory enhancement by post-training peripheral administration of low doses of dopamine agonists: possible autoreceptor effect. Behav. Neural Biol. 59:1993;230-241
50. Widzowski D.V., Cory-Slechta D.A. Apparent mediation of the stimulus properties of a low dose of quinpirole by dopaminergic autoreceptors. J. Pharmacol. Exp. Ther. 266:1993;526-534
51. Wise R.A., Schwarts H.V. Pimozide attenuates acquisition of lever pressing for food in rats. Pharmacol. Biochem. Behav. 15:1981;655-666
52. Yang C.R., Seamans J.K., Gorelova N. Developing a neural model for the pathophysiology of schizophrenia based on the nature of electrophysiological actions of dopamine in the prefrontal cortex. Neuropsychopharmacology. 21:1999;161-194